Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Dynavax Technologies (United States) | Researchclopedia

Back to institutions

Dynavax Technologies (United States)

Berkeley, Californiacompany

292

Works

75,342

Citations

140

h-index

Top Research Topics

Immunotherapy and Immune Responses Immune Response and Inflammation Immune Cell Function and Interaction

Top Researchers

Robert L. Coffman Dynavax Technologies (United States)

337 works74,475 citationsh-index: 113

Recent Research

A narrative review of immune-mediated adverse events in clinical trials of CpG oligonucleotide toll-like receptor 9 agonists

Robert S. Janssen,Robert L. Coffman

20260 citations

Hepatitis B Virus Studies

Cancer Immunotherapy and Biomarkers

Hepatitis C virus research

Asthma and respiratory diseases

Allergic Rhinitis and Sensitization

Hepatitis Viruses Studies and Epidemiology

T-cell and B-cell Immunology

SARS-CoV-2 and COVID-19 Research

Influenza Virus Research Studies

Paul M. O’Byrne St. Joseph’s Healthcare Hamilton

883 works55,202 citationsh-index: 111

Peter Openshaw British Lung Foundation

611 works47,777 citationsh-index: 105

Louis‐Philippe Boulet Institut universitaire de cardiologie et de pneumologie de Québec

629 works36,028 citationsh-index: 89

Dennis A. Carson University of California San Diego

580 works35,140 citationsh-index: 99

Jonathan W. Friedberg University of Rochester

722 works30,280 citationsh-index: 80

An H5N1 clade 2.3.4.4b virus vaccine that elicits cross-protective antibodies against conserved domains of H5 and N1 glycoproteins

Eduard Puente-Massaguer,Thales Galdino Andrade,et al.

20260 citations

A multicountry study to establish rates for pregnancy and neonatal outcomes in low- and middle-income regions

Antonella N. Tullio,Emad Yanni,et al.

20260 citations

411. Phase 1/2 Trial of an Investigational Herpes Zoster Vaccine with CpG 1018® Adjuvant and Shingrix in Healthy Adults 50 to 69 Years of Age

Oliver F. Medzihradsky,Rachel Graham,et al.

20260 citations

Compatibility and Stability of a Shigella Polysaccharide—Protein Conjugate Antigen Formulated with Aluminum Salt and CpG 1018® Adjuvants

Poorva Taskar,Prashant Kumar,et al.

20250 citations

Insights into hepatitis B vaccination decision-making: Exploring vaccine preferences, health disparities, and practice patterns among patients and healthcare providers

Melissa Scherkoske,James Moran,et al.

20251 citations